Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amisulpride 200mg tablets
0402010A0AAAAAA
|
Amisulpride | Amisulpride | Central Nervous System | 39,371 |
|
Amisulpride 100mg tablets
0402010A0AAAGAG
|
Amisulpride | Amisulpride | Central Nervous System | 30,786 |
|
Amisulpride 50mg tablets
0402010A0AAABAB
|
Amisulpride | Amisulpride | Central Nervous System | 22,428 |
|
Amisulpride 400mg tablets
0402010A0AAAEAE
|
Amisulpride | Amisulpride | Central Nervous System | 12,677 |
|
Amisulpride 100mg/ml oral solution sugar free
0402010A0AAAHAH
|
Amisulpride | Amisulpride | Central Nervous System | 1,269 |
|
Amisulpride 25mg/5ml oral liquid
0402010A0AAADAD
|
Amisulpride | Amisulpride | Central Nervous System | 11 |
|
Amisulpride 12.5mg/5ml oral liquid
0402010A0AAAJAJ
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
|
Amisulpride 200mg/5ml oral solution
0402010A0AAAMAM
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
|
Amisulpride 50mg/5ml oral liquid
0402010A0AAACAC
|
Amisulpride | Amisulpride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.